| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 19 securities · passive | ||||||
|
LendingTree, Inc.
13G/A
TREE · 52603B107
|
0% |
10/28/2026
Event 9/30/2026
|
||||
|
Rezolute, Inc.
13G
RZLT · 76200L309
|
5.5% |
10/28/2026
Event 9/30/2026
|
||||
|
Palvella Therapeutics, Inc.
13G/A
PVLA · 697947109
|
7.7% |
10/28/2026
Event 9/30/2026
|
||||
|
Heritage Financial Corp
13G/A
HFWA · 42722X106
|
8.8% |
10/28/2026
Event 9/30/2026
|
||||
|
Neurogene Inc.
13G
NGNE · 64135M105
|
11.1% |
10/6/2026
Event 9/30/2026
|
||||
|
Acadian Asset Management Inc
13G/A
AAMI · 10948W103
|
4.3% |
8/3/2026
Event 6/30/2026
|
||||
|
Summit Hotel Properties, Inc.
13G/A
INN · 866082100
|
10.8% |
7/2/2026
Event 6/30/2026
|
||||
|
Cabaletta Bio, Inc.
13G/A
CABA · 12674W109
|
11.4% |
6/4/2026
Event 5/29/2026
|
||||
|
Tarsus Pharmaceuticals, Inc.
13G/A
TARS · 87650L103
|
4.0% |
5/6/2026
Event 3/31/2026
|
||||
|
Riskified Ltd-A
13G/A
RSKD · M8216R109
|
0.7% |
5/6/2026
Event 3/31/2026
|
||||
|
GREAT LAKES DREDGE & DOCK CO
13G/A
GLDD · 390607109
|
1.5% |
5/6/2026
Event 3/31/2026
|
||||
|
Arcutis Biotherapeutics, Inc.
13G/A
ARQT · 03969K108
|
4.0% |
5/6/2026
Event 3/31/2026
|
||||
|
Plymouth Industrial REIT, Inc.
13G/A
PLYM · 729640102
|
3.4% |
1/30/2026
Event 12/31/2025
|
||||
|
Midwestone Financial Group I
13G/A
MOFG · 598511103
|
2.5% |
1/30/2026
Event 12/31/2025
|
||||
|
CAVA Group, Inc.
13G/A
CAVA · 148929102
|
0% |
11/5/2025
Event 9/30/2025
|
||||
|
Phathom Pharmaceuticals, Inc.
13G/A
PHAT · 71722W107
|
0% |
6/9/2025
Event 5/31/2025
|
||||
|
Bridge Investment Grp HDS-A
13G/A
BRDG · 10806B100
|
3.3% |
5/8/2025
Event 3/31/2025
|
||||
|
Adecoagro S.A.
13G/A
AGRO · L00849106
|
4.1% |
5/8/2025
Event 3/31/2025
|
||||
|
Shift4 Payments Inc-Class A
13G/A
FOUR · 82452J109
|
3.4% |
2/11/2025
Event 12/31/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.